Chelsea Therapeutics (CHTP) Slashed 20%+ on Trade Resumption
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) has resumed trading and is down 22 percent following an update on Northera.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulf Resources (GURE) Mentioned Catiously at White Diamond
- CTPartners Executive Search (CTP) Prices Public Offering at $3.44/Share
- Novogen Ltd. (NVGN) Trades at Session Highs
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!